Introduction
============

Ileoscopy at colonoscopy is a simple maneuver, which confirms the completeness of the procedure and improves the diagnostic yield. With an increasing number of ileal intubations, it is not uncommon to detect single or multiple ulcers in the terminal ileum [@JR660-1] [@JR660-2] [@JR660-3] . In patients with ileal and/or ileocolonic involvement on imaging modalities, these ulcers are always of clinical significance and help in establishing the diagnosis. On the other hand, most terminal ileal ulcers detected incidentally in asymptomatic patients can be ignored [@JR660-4] , but the etiology and clinical significance of these lesions in patients with abdominal symptoms have not been defined. The diagnosis of the specific cause of ileitis is important, because misdiagnosis may result in delays or errors in patient management.

The present study aimed at studying the etiology and clinical outcomes of ITIUs detected on ileocolonoscopy in patients with gastrointestinal symptoms at a tertiary care center in North India.

Material and methods
====================

Study design
------------

This prospective single center observational study was performed by evaluating consenting consecutive patients who underwent ileocolonoscopy for gastrointestinal symptoms (abdominal pain, altered bowel habits, overt or occult gastrointestinal bleed, fever, and weight loss) at the Endoscopy unit in the Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India from 1 January 2014 through 31 December 2014. Patients who showed single or multiple ITIUs as the sole endoscopic abnormality were recruited prospectively. Patients who refused to consent, had incomplete colonoscopy (due to colonic strictures or growths), colonic or ileocecal ulcers and those with abnormalities on abdominal imaging (CT/MRI) were excluded. The study protocol was approved by the institutional ethics committee.

Data collection
---------------

For recruited patients, the data collected included demographic data (including age and gender), clinical features and their duration, history of NSAID intake, laboratory investigations (including complete blood counts, inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), serum protein and albumin, antibodies to tissue transglutaminase, serum vitamin B12, D-xylose test, anti-human immunodeficiency virus (HIV) antibodies, anti nuclear antibodies (ANA), stool examination for parasites including special stains for opportunistic pathogens, stool culture, chest radiograph, Mantoux test and special tests such as tissue polymerase chain reaction (PCR) for tuberculosis (TB) or cytomegalovirus where required), colonoscopic and histological findings, initial diagnosis and treatment given. The patients were followed up clinically and a repeat colonoscopy with biopsies was done after 3 to 6 months, if the patient gave consent.

Colonoscopy was done with video-colonoscope (CF-Q160 L, Olympus Medical Systems Corp, Tokyo, Japan) under conscious sedation after preparation with polyethylene glycol electrolyte lavage solution. In patients with ITIUs, biopsies (minimum four in number) were taken from the ulcer margins and base, and sent in formalin for histopathology. The parameters used for arriving at a diagnosis of ITIUs are summarized in [Table 1](#TB660-1){ref-type="table"} . Patients diagnosed with ITIU were started on treatment based on the etiology as determined by clinical, endoscopic, and histological findings; these are also summarized in [Table 1](#TB660-1){ref-type="table"} .

###### Diagnostic parameters used and initial treatment given.

  Diagnosis                                         Colonoscopy                                                            Histology                                                                                                         Others                                                                                                                                                                      Treatment given
  ------------------------------------------------- ---------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------
  Crohn's disease: ECCO guidelines [@JR660-18]      ITIUs and/or erosions                                                  Focal/patchy chronic lymphoplasmacytic inflammation, irregular villus architecture, crypt distortion, granuloma   No response/worsening/worsening after initial improvement with standard antitubercular treatment AND subsequent clinical response to oral steroids [@JR660-19]              Pentasa and Budesonide
  Intestinal tuberculosis [@JR660-20] [@BR660-21]   ITIUs and/or erosions                                                  Confluent, caseating granulomas containing acid fast bacilli and surrounded by a lymphoid cuff                    Response to anti-tubercular treatment                                                                                                                                       Anti-tubercular therapy
  NSAID-induced ulcers [@JR660-22]                  ITIUs and/or erosions                                                  No specific histological features                                                                                 History of NSAID intake AND symptom resolution with cessation of NSAIDs, after exclusion of other causes (malignancy, inflammatory bowel disease, and infectious disease)   Withdrawal of NSAIDs
  Eosinophilic enteritis [@JR660-23] [@JR660-24]    ITIUs and/or nodular or polypoid ileal mucosa, erythema, or erosions   More than 30 eosinophils per high power field on histopathology                                                   After excluding other causes of eosinophilia (infections, parasitic infestation, inflammatory bowel disease, celiac disease, connective tissue disorders)                   Six-Food Elimination Diet and/or steroids
  Nonspecific ulcers [@JR660-4]                     ITIUs and/or erosions                                                  Focal cryptitis, crypt distortion, acute or chronic inflammatory cells without granulomas, basal plasmacytosis                                                                                                                                                                                Symptomatic treatment

The patients were followed up for improvement or resolution of symptoms within 3 -- 6 months of the initial diagnosis, and colonoscopy was repeated for consenting patients.

Statistical analysis
--------------------

Continuous data were expressed as mean ± SD or median as appropriate. Categorical variables were expressed as percentages. Chi-squared test was used to compare various parameters of demographic information, clinical presentation, colonoscopic findings, laboratory values, and histological features with the initial clinical diagnosis to evaluate the presence of any pattern. *P-* values of \< 0.05 were considered to be statistically significant. SPSS software version 22 was used for data analysis.

Results
=======

The patient disposition is summarized in [Fig. 1](#FI660-1){ref-type="fig"} .

![Patient flow chart.](10-1055-s-0043-100688-i660ei1){#FI660-1}

A total of 1497 ileocolonoscopies were performed for various indications between 1 January 2014 and 31 December 2014. Patients in whom the ileum was not intubated due to distal obstruction or technical problems were excluded. Abnormal findings were seen in 439 (29.3 %) of the patients, and ITIUs were seen in 74 patients from the 1497 ileocolonoscopies (4.9 %). Abdominal imaging (CT/MRI) for these patients was normal. Specific etiologies such as Crohn's disease, intestinal tuberculosis, NSAID enteropathy, and eosinophilic enteritis were established in more than half of these patients.

The demographic and other details of the patients are summarized in [Table 2](#TB660-2){ref-type="table"} . The mean age of the patients with ITIUs was 37.78 ± 14.43 years, and 55 out of 74 patients were male. The median duration of symptoms was longest in Crohn's disease (5.6 years) and shortest in NSAID induced ulcers. The three most common presenting symptoms among all patients with ITIUs included chronic diarrhea (77 %), pain (59.5 %), and weight loss (37.8 %).

###### Demographic details, clinical presentation, laboratory parameters, colonoscopic, and histologic findings of patients sorted according to diagnosis.

                                                         Crohn's disease (n = 18)   Tuberculosis (n = 7)   NSAIDs (n = 11)   Eosinophilic enteritis (n = 5)   Nonspecific ulcers (n = 33)   Total (n = 74)   *P* -value (Chi-squared test)
  ------------------------------------------------------ -------------------------- ---------------------- ----------------- -------------------------------- ----------------------------- ---------------- -------------------------------------------------
  **Demographics**                                                                                                                                                                                           
  Age, mean ± SD, years                                  32.28 ± 10.95              37.29 ± 12.47          40.36 ± 16.44     42.2 ± 2.86                      39.36 ± 16.48                 37.78 ± 14.43     -- 
  Gender, M/F                                            15/3                        6/1                    5/6               1/4                             28/5                          55/19             -- 
  Median symptom duration, months                        67.2                       11.6                    2.4               3.5                              3.1                          17.48             -- 
  **Clinical presentation and laboratory parameters**                                                                                                                                                        
  Pain                                                   10 (55.6 %)                 7 (100 %)              6 (54.5 %)        3 (60 %)                        18 (54.5 %)                   44 (59.5 %)      0.255
  Diarrhea                                               15 (83.3 %)                 5 (71.4 %)            10 (90.9 %)        4 (80 %)                        23 (69.7 %)                   57 (77 %)        0.6
  Constipation                                            2 (11.1 %)                 2 (28.6 %)             2 (18.2 %)        1 (20 %)                        10 (30.3 %)                   17 (23 %)        0.605
  Gastrointestinal bleeding (overt)                       3 (16.7 %)                 0 (0 %)                4 (36.4 %)        0 (0 %)                          0 (0 %)                       7 (9.5 %)       **0.005 [1](#FN660-1){ref-type="table-fn"}**
  Gastrointestinal bleeding (occult)                      1 (5.6 %)                  0 (0 %)                0 (0 %)           0 (0 %)                          5 (15.2 %)                    6 (8.1 %)       0.357
  Fever                                                   4 (22.2 %)                 3 (42.9 %)             3 (27.3 %)        1 (20 %)                         3 (9.1 %)                    14 (18.9 %)      0.256
  Weight loss                                             9 (50 %)                   5 (71.4 %)             3 (27.3 %)        2 (40 %)                         9 (27.3 %)                   28 (37.8 %)      0.159
  Oral ulcers                                             5 (27.8 %)                 1 (14.3 %)             0 (0 %)           0 (0 %)                          0 (0 %)                       6 (8.1 %)       **0.007** [1](#FN660-1){ref-type="table-fn"}
  Anemia (Hb \< 12 g/dL for women; \< 13 g/dL for men)    3 (16.7 %)                 2 (28.6 %)             4 (36.4 %)        0 (0 %)                          0 (0 %)                       9 (12.2 %)      0.009
  Elevated CRP levels (Normal: 0 -- 10 mg/L)              6 (33.3 %)                 3 (42.9 %)             0 (0 %)           0 (0 %)                          0 (0 %)                       9 (12.2 %)      **\< 0.001** [1](#FN660-1){ref-type="table-fn"}
  **Colonoscopic findings**                                                                                                                                                                                  
  Ulcer size                                                                                                                                                                                                 
   \< 5 mm                                               10 (55.6 %)                 6 (85.7 %)            11 (100 %)         5 (100 %)                       22 (66.7 %)                   54 (73 %)        **0.42** [1](#FN660-1){ref-type="table-fn"}
   \> 5 mm                                                8 (44.4 %)                 1 (14.3 %)             0 (0 %)           0 (0 %)                         11 (33.3 %)                   20 (27 %)        
  Ulcer number                                                                                                                                                                                               
  1                                                       0 (0 %)                    0 (0 %)                0 (0 %)           0 (0 %)                         10 (30.3 %)                   10 (13.5 %)      **\< 0.001** [1](#FN660-1){ref-type="table-fn"}
  2 -- 3                                                  8 (44.4 %)                 4 (57.1 %)             2 (18.2 %)        0 (0 %)                          2 (6.1 %)                    16 (21.6 %)      
  Multiple                                               10 (55.6 %)                 3 (42.9 %)             9 (81.8 %)        5 (100 %)                       21 (63.6 %)                   48 (64.9 %)      
  Nodules                                                 0 (0 %)                    3 (42.9 %)             0 (0 %)           (0 %)                            0 (0 %)                       3 (4.1 %)       **\< 0.001** [1](#FN660-1){ref-type="table-fn"}
  Erosions                                                8 (44.4 %)                 3 (42.9 %)             5 (45.5 %)        0 (0 %)                          0 (0 %)                      16 (21.6 %)      **\< 0.001** [1](#FN660-1){ref-type="table-fn"}
  Strictures                                              0 (0 %)                    1 (14.3 %)             1 (9.1 %)         0 (0 %)                          0 (0 %)                       2 (2.7 %)       0.145
  **Histology**                                                                                                                                                                                              
  Villi appearance (normal)                              15 (83.3 %)                 7 (100 %)             11 (100 %)         5 (100 %)                       33 (100 %)                    71 (95.9 %)      **0.45** [1](#FN660-1){ref-type="table-fn"}
  Villi appearance (blunted)                              3 (16.7 %)                 0 (0 %)                0 (0 %)           0 (0 %)                          0 (0 %)                       3 (4.1 %)       
  Epithelial erosion/ulcer                                7 (38.9 %)                 1 (14.3 %)             7 (63.6 %)        2 (40 %)                        11 (33.3 %)                   28 (37.8 %)      0.281
  Cryptitis                                              15 (83.3 %)                 0 (0 %)                2 (18.2 %)        3 (60 %)                         0 (0 %)                      20 (27 %)        **\< 0.001** [1](#FN660-1){ref-type="table-fn"}
  Crypt distortion                                        7 (38.9 %)                 0 (0 %)                0 (0 %)           0 (0 %)                          0 (0 %)                       7 (9.5 %)       **\< 0.001** [1](#FN660-1){ref-type="table-fn"}
  Crypt abscess                                           3 (16.7 %)                 0 (0 %)                0 (0 %)           0 (0 %)                          0 (0 %)                       3 (4.1 %)       **0.45** [1](#FN660-1){ref-type="table-fn"}
  Eosinophilia                                            3 (16.7 %)                 0 (0 %)                4 (36.4 %)        5 (100 %)                        3 (9.1 %)                    15 (20.3 %)      **\< 0.001** [1](#FN660-1){ref-type="table-fn"}
  Granuloma                                               3 (16.7 %)                 4 (57.1 %)             0 (0 %)           0 (0 %)                          0 (0 %)                       7 (9.5 %)       **\< 0.001** [1](#FN660-1){ref-type="table-fn"}

NSAIDs, non-steroidal anti-inflammatory drugs; CRP: C-reactive protein.

Significant finding.

CRP level elevation and oral ulcers were only observed in patients with Crohn's disease and tuberculosis ( *P*  = 0.007 for oral ulcers; *P*  \< 0.001 for elevated CRP levels). Overt gastrointestinal bleeding was encountered more commonly in patients having Crohn's disease and NSAID-induced ulcers ( *P*  = 0.005). The pattern of distribution of other symptoms was not statistically significant: anemia was encountered in patients having Crohn's disease, TB, or NSAID-induced ulcers, and constipation and occult gastrointestinal bleeding were more often seen in patients with nonspecific ulcers. The small sample size and large number of diagnoses prevented us from performing a multivariate analysis.

Determining etiology of ITIUs based on endoscopic findings ( [Fig. 2](#FI660-2){ref-type="fig"} ) was difficult. Ulcers (100 %) and erosions (21.6 %) were the commonest ileoscopic findings. Three patients had mucosal nodularity (all had ITB) and two (one each with CD and ITB) had strictures. All patients with eosinophilic enteritis had multiple ulcers, and solitary ulcers were only seen in patients having nonspecific ulcers ( *P*  \< 0.001).

![ Endoscopic findings in patients with isolated terminal ileal ulcers. Ileoscopy images showing erosions ( **a** , **b** ); ulcers ( **c**  --  **e** ), and mucosal nodularity ( **f** ).](10-1055-s-0043-100688-i660ei2){#FI660-2}

Only patients with Crohn's disease demonstrated blunted villi ( *P*  = 0.45), cryptitis, crypt distortion ( *P*  \< 0.001 for both), and crypt abscesses ( *P*  = 0.45). Granulomas were seen in seven patients, four of whom were treated as ITB and three as Crohn's disease ( *P*  \< 0.001). Of the 15 patients with eosinophilic infiltrate, three had histology suggestive of CD, four had a history of NSAIDs, and five were diagnosed to have eosinophilic enteritis ( *P*  \< 0.001) ( [Fig. 3](#FI660-3){ref-type="fig"} ).

![ Histological findings in patients with isolated terminal ileal ulcers. Crohn's disease ( **a**  --  **c** ): **a** Ileal ulceration with granulomatous reaction in the lamina propria (H&E, 100 ×); **b** Crypt distortion (H&E, 400 × ); **c** Crypt abscess (H&E, 400 ×). Tuberculosis ( **d** , **e** ): **d** Normal villous pattern with extensive granulomatous reaction in one of the biopsy samples (H&E, 100 ×); **e** Epithelioid cell granulomas with Langhans giant cell reaction and necrosis (H&E, 200 ×); Eosinophilic ileitis ( **f** , **g** ): **f** Ileum biopsy showing ulceration with inflammatory granulation predominantly comprised of eosinophils (H&E, 200 ×); **g**  \> 30 Eosinophils/HPF in the lamina propria (H&E, 400 ×); Nonspecific acute ileitis ( **h** , **i** ): **h** Erosion of the epithelium (H&E, 200 ×); **i** Acute and chronic inflammation in the lamina propria, no cryptitis, no crypt abscess, no granuloma (H&E, 400 ×).](10-1055-s-0043-100688-i660ei3){#FI660-3}

Out of the initial 74 patients, 60 returned for follow-up 3 -- 6 months after treatment initiation, and the initial symptoms had resolved in 55 (91.7 %) of these 60 patients. The five patients who had persistent symptoms (three treated as nonspecific ulcers, and two as Crohn's disease) underwent repeat ileocolonoscopy which revealed persistence of multiple ITIUs. The three patients who were initially diagnosed to have nonspecific ileitis had now developed villous abnormalities, cryptitis, crypt abscesses (one had granulomas), and were diagnosed and treated as Crohn's disease. Two patients who were treated as Crohn's disease (in view of chronic inflammatory infiltrates in lamina propria with cryptitis, no evidence of granulomas or acid fast bacilli) continued to be symptomatic (pain in abdomen, chronic diarrhea, anemia, no fever). Repeat evaluation showed persistence of ITIUs and biopsies revealed granulomas suggestive of tuberculosis. These patients were started on anti-tubercular treatment. In addition to these five patients, repeat ileocolonoscopy was also performed in consenting patients with symptom resolution (n = 31), and TIU resolution was observed in 28 of the 36 patients (77.8 %). The follow-up details are summarized in [Table 3](#TB660-3){ref-type="table"} .

###### Follow-up details of patients.

  Initial diagnosis        Initial number of patients   Number of patients followed up   Symptom resolution   Number of patients with colonoscopic follow-up   TIU resolution
  ------------------------ ---------------------------- -------------------------------- -------------------- ------------------------------------------------ ----------------
  Crohn's disease          18                           14                               12 (85.7 %)          11                                                9 (81.8 %)
  Tuberculosis              7                            5                                5 (100 %)            2                                                0 (0 %)
  NSAIDs                   11                           11                               11 (100 %)            1                                                1 (100 %)
  Eosinophilic enteritis    5                            3                                3 (100 %)            3                                                2 (66.7 %)
  Nonspecific ulcers       33                           27                               24 (88.9 %)          19                                               16 (84.2 %)
  Total                    74                           60                               55 (91.7 %)          36                                               28 (77.8 %)

NSAIDs, non-steroidal anti-inflammatory drugs; TIU, terminal ileal ulcer.

Discussion
==========

Though there are studies describing the clinical course and follow up of asymptomatic terminal ileitis [@JR660-4] [@JR660-5] [@JR660-6] , data on symptomatic terminal ileal ulcers is sparse. This study was conducted with an aim to understand the etiology and clinical outcomes of ITIU detected on ileocolonoscopy in patients with gastrointestinal symptoms. We found that 74 out of 1497 (4.9 %) patients who underwent ileocolonoscopy had ITIUs, and specific etiologies could be ascertained initially in 41 (55.4 %) of these 74 patients. By the end of the follow-up period, a definitive diagnosis was made in a total of 44 (59.5 %) patients. The final tally of diagnoses was Crohn's disease: 19 (25.7 %), NSAID-induced ulcers: 11 (14.9 %), intestinal tuberculosis: 9 (12.2 %), eosinophilic enteritis: 5 (6.8 %), and nonspecific ulcers: 30 (40.5 %). None of our patients with gastrointestinal symptoms and ITIUs had vasculitis, lymphomas or malignancies.

Out of the various clinical presentations considered, the three commonest symptoms were pain, diarrhea, and weight loss, irrespective of the final diagnosis. In addition to these, oral ulcers and elevated CRP levels were more commonly seen in Crohn's disease or tuberculosis, while overt gastrointestinal bleeding was seen in patients with NSAID enteropathy and Crohn's disease. Our findings were different from a recent study from India [@JR660-7] where patients with Crohn's disease or tuberculosis had significantly more symptoms than those with nonspecific ulcers. In patients with nonspecific ulcers, 89.5 % of the symptomatic patients in their study had specific pathology such as tuberculosis/Crohn's disease, diagnosed based on ileal thickening on imaging. Thirty-eight percent of their patients with nonspecific ulcers were asymptomatic and most of those (91 %) were managed symptomatically [@JR660-7] . On the other hand, our series included symptomatic patients with normal imaging and 40.5 % of these had nonspecific ulcers, which responded to symptomatic management.

On ileocolonoscopy, all ITIUs appeared alike, though ulcers with specific etiologies were multiple, and single ulcers were all of a nonspecific etiology. Ileal nodules, erosions, and strictures were only noted in patients with Crohn's disease, tuberculosis, or NSAID enteropathy. Histological diagnosis was fairly accurate in most of the patients and they responded favorably to the treatment provided. The most frequent specific diagnosis for ITIUs obtained in our study was Crohn's disease. This is consistent with previously reported series [@JR660-8] [@JR660-9] . In countries such as India where tuberculosis continues to be highly prevalent, differentiating Crohn's disease from tuberculosis is a challenging task. Both of these diseases have similar features such as weight loss, CRP elevation, and granulomas on histological examination. Two of our patients diagnosed with Crohn's continued to have symptoms and were diagnosed with tuberculosis on follow up. Testing these patients with tissue TB-PCR or Interferon gamma release assays (Quantiferon TB gold) may have helped in increasing the diagnostic yield in these patients [@JR660-10] . Nonspecific terminal ileal ulcers were noted in 33 of the 74 patients (44.6 %). Most of these (88.9 %) responded to symptomatic management and 84 % had endoscopic resolution on follow-up, thus highlighting the fact that nonspecific terminal ileal ulcers have a benign clinical course and are not associated with any serious complications that may need surgical intervention. Similar findings were noted in a study from China [@JR660-11] , where seven patients were followed up for 7 years. Colonic lavage using polyethylene glycol (PEG) or sodium phosphate before colonoscopy can also cause aphthous ulcers in the intestines [@JR660-12] [@JR660-13] [@JR660-14] . These ulcers are more commonly seen in patients prepared with sodium phosphate [@JR660-12] . Though our patients were prepared with PEG, some of the nonspecific ulcers which resolved on follow-up could have been due to colonic lavage. Patients with NSAID enteropathy and eosinophilic enteritis had complete symptom resolution on follow-up.

Overall, complete symptom resolution was observed in 55 out of 60 patients (91.7 %) who returned for follow-up, and endoscopic resolution was found in 28 out of 36 patients (77.8 %) who consented to a repeat endoscopy. Only five out of the 60 follow-up patients did not report symptom resolution. Three of these were initially diagnosed as nonspecific ulcers and two patients with Crohn's disease, and they were finally diagnosed with Crohn's disease and tuberculosis, respectively, and treated accordingly. The use of newer surrogate markers of inflammation such as serum calprotectin [@JR660-15] [@JR660-16] and lactoferrin [@JR660-17] in these nonspecific ulcers could have aided in early diagnosis of these diseases.

The limitations of our study include its small sample size, which prevented us from performing a multivariate analysis of the symptom profile predicting a diagnosis of ITIUs, and a relatively short-term follow up. We also did not include tissue TB-PCR or fecal calprotectin in our diagnostic tests which would have been a valuable tool to help in the diagnosis of intestinal tuberculosis or inflammatory bowel disease.

To conclude, we have observed from our study that over half of the patients with symptomatic ITIUs may have specific etiologies, and hence require appropriate evaluation. Since colonoscopic findings alone cannot accurately predict the etiology, laboratory and histological examinations are definitely required. Pointers towards a diagnosis of Crohn's disease include elevation of CRP and histological demonstrations of blunted villi and crypt changes, whereas strictures and nodules on colonoscopy (which are not picked up on CT/MRI due to small size) and granulomas on histology point towards a diagnosis of intestinal tuberculosis. Accurate diagnosis will result in early initiation of appropriate treatment, which can prevent complications such as strictures, blood loss, and dissemination of TB to other organs. Patients with nonspecific histological findings can be managed symptomatically; however, they should be monitored closely and if symptoms persist on treatment, repeat endoscopy and histopathology should be considered within 3 -- 6 months for confirmation of diagnosis.
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